NasdaqGS - Nasdaq Real Time Price USD

Halozyme Therapeutics, Inc. (HALO)

Compare
52.80
-0.96
(-1.79%)
At close: January 10 at 4:00:02 PM EST
52.80
0.00
(0.00%)
After hours: January 10 at 5:59:19 PM EST

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
CONNAUGHTON BERNADETTE M. Director Stock Award(Grant) Apr 25, 2024 46,787
HENDERSON JEFFREY WILLIAM Director Sale Jan 6, 2025 43,611
KRISHNAN MAHESH M.D., MPH Director Stock Award(Grant) Apr 25, 2024 6,501
LABARRE MICHAEL J. Chief Technology Officer Conversion of Exercise of derivative security Oct 16, 2024 173,756
LABROSSE NICOLE Chief Financial Officer Conversion of Exercise of derivative security Jul 22, 2024 15,480
MATSUI CONNIE L Director Stock Gift Nov 29, 2024 183,035
MIYASHITA AKIKO MONI Director Stock Award(Grant) Apr 25, 2024 20,772
POSARD MATTHEW L Director Sale Aug 14, 2024 69,874
SNYDER MARK HOWARD Officer Conversion of Exercise of derivative security Jan 3, 2025 15,002
TORLEY HELEN I Chief Executive Officer Stock Gift Nov 29, 2024 666,744

Related Tickers